Open AccessEfficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
Author(s) -
Thomas Raber,
Ines Lanzl
Publication year - 2011
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s16355
Subject(s) - timolol , medicine , tolerability , ophthalmology , intraocular pressure , anesthesia , pharmacology , adverse effect
The purpose of this study was to document the efficacy and tolerability of the new fixed-combination (FC) brinzolamide 1%/timolol 0.5% as used in daily practice throughout Germany.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom